NervGen Pharma Corp. Common stock (NGEN)
NGEN Stock Price Chart
Explore NervGen Pharma Corp. Common stock interactive price chart. Choose custom timeframes to analyze NGEN price movements and trends.
NGEN Company Profile
Discover essential business fundamentals and corporate details for NervGen Pharma Corp. Common stock (NGEN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
8 Feb 2021
Employees
7.00
Website
https://www.nervgen.comCEO
Adam H. Rogers
Description
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.
NGEN Financial Timeline
Browse a chronological timeline of NervGen Pharma Corp. Common stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 Aug 2026
EPS estimate is -$0.09, while revenue estimate is $4.50k.
Earnings released on 18 May 2026
EPS came in at -$0.01 surpassing the estimated -$0.07 by +80.35%.
Earnings released on 31 Mar 2026
EPS came in at -$0.26 falling short of the estimated -$0.06 by -304.58%.
NGEN Stock Performance
Access detailed NGEN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
